- Mysterious White Blood Cell Disorder Not Just 'AIDS Without HIV'
- Comorbidity Burden in People With HIV Tied to Increased Mortality Risk
- For People With HIV, Early Anal Cancer Screening Tied to Better Outcomes
- Long-Acting HIV Drug Promising for Treatment-Naive Patients
- Novel Capsid Inhibitor Approved for Super-Refractory HIV
- HIV Prevention, Care Showed Resilience During the COVID Pandemic
- CDC: HIV Coinfection in Over 80% of Hospitalized Monkeypox Cases
- Stigma, Health Discrimination Common for Hispanic Adults With HIV
- Higher Risk of Severe Breakthrough COVID for Certain HIV Patients
- Lung Cancer Declining in People With HIV, but Still High
- First-Line HIV Treatment Proves Mettle in Pregnant Patients
- Patients With HIV at Higher Risk for COVID Breakthrough Infections
- Advocates to Government: 'Go Big' on HIV Prevention Efforts
- FDA Approves First Long-Acting Injectable to Prevent HIV Infection
- Biden Unveils Plan to Hasten 'End' of HIV Epidemic
- Black, Hispanic Men Left Behind on Declining HIV Rates in the U.S.
- Sex Disparity Mars Rollout of Embattled HIV Treatment in Poorer Countries
- Year in Review: HIV
- High-Dose HBV Revaccination Better Protects HIV Patients
- Long-Acting Injectable for HIV Prevention Passes Hurdles, but Barriers Remain
- The Moon Landing of HIV Vaccine Research: RV144, Ten Years Later
- In 1995, There Was No AIDS Conference -- Here's What Happened in 1994
- Good News, Bad News for CRISPR Gene Editing for HIV Cure
- Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?
- CDC: Untreated HIV Infections Barrier to Ending Epidemic
- HHS Leaders Sketch Plan to End HIV/AIDS by 2030
- World AIDS Day: Positive Steps, but No End in Sight
- USPSTF Backs HIV PrEP for High-Risk Patients
- Supervised Injection Sites Reduce Drug-Related Harm
- Scaled-Up PrEP Cut New HIV Cases in Australia
- Longer Term Tx Success Seen in HIV Patients After Allo-HSCT
- HIV Diagnoses Up Among Younger MSM
- Major Boost in Viral Suppression Rates in HIV Patients in U.S.
- Ibalizumab Shows Antiviral Activity in Multi-Drug Resistant HIV
- HIV Vax Candidate 'Defines Additional Path' for Preclinical Data
- Adults at High Risk for HIV Not Testing as Often as Recommended
- Use of 'Chemsex' Ups Risk of HIV Dx Among Gay and Bisexual Men
- FDA Warns of Birth Defects from HIV Drug Dolutegravir
- HIV Patients to See Shift in Cancer Trends by 2030
- Has Basic Science in HIV Research Stalled?
- Engineered Stem Cells Show Promise vs HIV (STAT)
- Genius Delayed: HIV Vaccines Still in the Works
- World AIDS Day Picture Mixed
- FDA Gives Nod to Two-Drug HIV Combo
- Morning Break: Gaming the Price of Cancer Drug; Handel's Back Story; Feds Tracking Saline
- HIV Pioneer Mark Wainberg Dies
- HIV in America: New York City Was First 'Hub'
- Culture Shock: End of HIV/AIDS Still Not in Sight
- Opinion Makers: End of AIDS in Sight?
- HIV Prevention: Are Doctors the Problem?
- FDA Approves Single-Pill HIV Combo
- HIV Case Linked to Lesbian Sex
- HIV Cure Experiment 'Disappointing'
- 30 Years of HIV: Looking Back, Looking Ahead
- FDA Panel Says Yes to Home HIV Test
- FDA Staff Flags False Results of Home HIV Test
- Medicare to Cover Some HIV Facial Atrophy Shots
- HIV Testing Often Comes Late in Course of Infection
- HIV-Positive Surgeon Allowed Back into OR
- Nobel for HIV Discovery Goes to French and HPV to German
- Anti-HIV Gel Found Safe for Daily Use as Putative Microbicide
- Generic Tenofovir (Viread) Approved
- Crystal Meth Use High Among Gay Men in the Southeast